IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Memantine in Patients With Chronic Glaucoma
This study has been completed.
Sponsor:
Allergan
Information provided by:
Allergan
ClinicalTrials.gov Identifier:
NCT00141882
First received: August 31, 2005
Last updated: November 3, 2010
Last verified: November 2010
| Tracking Information | |||
|---|---|---|---|
| First Received Date ICMJE | August 31, 2005 | ||
| Last Updated Date | November 3, 2010 | ||
| Start Date ICMJE | March 1999 | ||
| Primary Completion Date | January 2006 (Final data collection date for primary outcome measure) | ||
| Current Primary Outcome Measures ICMJE |
Progression of glaucoma | ||
| Original Primary Outcome Measures ICMJE | Same as current | ||
| Change History | Complete list of historical versions of study NCT00141882 on ClinicalTrials.gov Archive Site | ||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||
| Current Other Outcome Measures ICMJE | Not Provided | ||
| Original Other Outcome Measures ICMJE | Not Provided | ||
| Descriptive Information | |||
| Brief Title ICMJE | Memantine in Patients With Chronic Glaucoma | ||
| Official Title ICMJE | Not Provided | ||
| Brief Summary | Randomized double-masked clinical trial of memantine in patients with glaucoma | ||
| Detailed Description | Not Provided | ||
| Study Type ICMJE | Interventional | ||
| Study Phase | Phase 3 | ||
| Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
||
| Condition ICMJE | Open-Angle Glaucoma | ||
| Intervention ICMJE | Drug: memantine | ||
| Study Arms | Not Provided | ||
| Publications * | Not Provided | ||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
| Recruitment Information | |||
| Recruitment Status ICMJE | Completed | ||
| Enrollment ICMJE | 1119 | ||
| Completion Date | August 2006 | ||
| Primary Completion Date | January 2006 (Final data collection date for primary outcome measure) | ||
| Eligibility Criteria ICMJE | Inclusion Criteria:
|
||
| Sex/Gender |
|
||
| Ages | 18 Years to 80 Years (Adult, Senior) | ||
| Accepts Healthy Volunteers | No | ||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||
| Listed Location Countries ICMJE | Not Provided | ||
| Removed Location Countries | |||
| Administrative Information | |||
| NCT Number ICMJE | NCT00141882 | ||
| Other Study ID Numbers ICMJE | 192944-004 | ||
| Has Data Monitoring Committee | No | ||
| U.S. FDA-regulated Product | Not Provided | ||
| IPD Sharing Statement | Not Provided | ||
| Responsible Party | Not Provided | ||
| Study Sponsor ICMJE | Allergan | ||
| Collaborators ICMJE | Not Provided | ||
| Investigators ICMJE | Not Provided | ||
| PRS Account | Allergan | ||
| Verification Date | November 2010 | ||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||